SABCS 2021


Tucatinib | Breast Cancer | Abstract #396

HER2CLIMB-04: Phase 2 trial of tucatinib + trastuzumab deruxtecan in patients with HER2+ locally advanced or metastatic breast cancer with and without brain metastases (trial in progress)

Tucatinib | Breast Cancer | Abstract #858

Updated results of tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases (HER2CLIMB)

Tucatinib | Breast Cancer | Abstract #207

SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: HER2-mutated breast cancer cohort (ongoing clinical trial)

Enfortumab Vedotin | Solid Tumors | Abstract #139

EV-202: Phase 2 Trial-in-Progress of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors, Including Breast Cancer